期刊文献+

依那西普联合甲氨蝶呤治疗强直性脊柱炎的近期放射学进展与生活质量相关分析 被引量:6

Radiological progression and life quality analysis in ankylosing spondylitis patients using etanercept/methotrexate combination therapy
原文传递
导出
摘要 目的 探讨依那西普联合甲氨蝶呤治疗强直性脊柱炎患者的影像学进展和生活质量的相关性.方法 2006年11月至2009年1月中山大学附属第一医院,153例符合1984年修订的强直性脊柱炎纽约标准的强直性脊柱炎患者接受依那西普联合甲氨蝶呤治疗,随访1年,分别在基线状态、治疗后3、6和12个月时以mSASSS评价影像学进展,应用SF-36量表来评价生活质量,并记录其临床缓解,分析三者之间相互关联.结果 所有患者影像学进展不明显.大部分患者生活质量治疗后改善明显.BASDAI指数、CRP和ESR等指标均有相同倾向.生活质量和mSASSS评分之间无相关性,但与临床症状缓解显著相关.结论 依那西普联合甲氨蝶呤可显著提高强直性脊柱炎患者的生活质量,但临床症状缓解和疼痛控制并不能提示影像学进展的好转.即使生活质量指数已达较高水平,仍需影像学随访. Objective To analyze the relationship between the radiological progression and quality of life in ankylosing spondylitis (AS) patients using etanercept/methotrexate (MTX) combination therapy. Methods A total of 153 AS cases fulfilling the 1984 modified New York diagnostic criteria were reviewed. All patients received radiological evolution at baseline and during a follow-up period. Radiological progression, clinical remission and life quality were recorded and analyzed for their relations. Results The radiological assessments of mSASSS (modified Stoke ankylosing spondylitis spine score) were recorded at baseline, 3, 6 & 12 months after treatment. Life quality assessments were recorded with SF (short-form) -36simultaneously. No significant radiological improvement was observed at the end points. However, most patients reported a significant improvement of life quality after a combination therapy of etanercept/MTX. BASDAI (Bath ankylosing spondylitis disease activity index), C-reactive protein and erythrocyte sedimentation rate demonstrated similar trends. With no relevance with mSASSS, life quality was significantly correlated with disease activity and pain control. Conclusion The combination therapy of etanercept/MTX greatly improves lfie quality in AS patients. Yet clinical remission and pain control offer no hint of a suspension of radiological progression. Routine radiological assessment is required throughout the follow-up period of AS even if life quality index reaches a high level.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第15期1022-1025,共4页 National Medical Journal of China
关键词 脊柱炎 强直性 放射学 生活质量 健康调查 Spondylitis,ankylosing Radiology Quality of life Health survey
  • 相关文献

参考文献20

  • 1Keat A,Barkham N,Bhalla A,et al.BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis.Report of a working party of the British Society for Rheumatology.Rheumatology (Oxford),2005,44:939-947.
  • 2Dagfinrud H,Kvien TK,Hagen KB.Physiotherapy interventions for ankylosing spondylitis.Cochrane Database Syst Rev,2008,1:CD002822.
  • 3Davis JC,van der Heijde D,Dougados M,et al.Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy.Arthritis Rheum,2005,53:494-501.
  • 4Lambert RG,Salonen D,Rahman P,et al.Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis:a multicenter,randomized,double-blind,placebo-controlled study.Arthritis Rheum,2007,56:4005-4014.
  • 5Braun J,Brandt J,Listing J,et al.Treatment of active ankylosing spondylitis with infliximab:a randomized controlled multicentre trial.Lancet,2002,359:1187 -1193.
  • 6Gorman JD,Sack KE,Davis JC.Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.N Engl J Med,2002,346:1349-1356.
  • 7Boonen A,Patel V,Traina S,et al.Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving Etanercept.J Rheumatol,2008,35:662-667.
  • 8盘晓燕,李娟,庞捷,戴森华,陈卫国.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗活动性强直性脊柱炎的临床评价[J].中华医学杂志,2008,88(20):1408-1411. 被引量:8
  • 9van der Heijde D,Salonen D,Weissman BN,et al.Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.Arthritis Res Ther,2009,11:R127.
  • 10Strand V,Singh JA.Newer biological agents in rheumatoid arthritis:impact on health-related quality of life and productivity.Drugs,2010,70:121-145.

二级参考文献42

  • 1杨春花,黄烽,赵绵松,古洁若,张汉伟,余得恩.基质金属蛋白酶-3与强直性脊柱炎疾病活动相关性研究[J].中华风湿病学杂志,2004,8(10):577-582. 被引量:14
  • 2中华外科杂志编辑部.股骨头缺血性坏死专题讨论会纪要[J].中华外科杂志,1994,32:549-549.
  • 3Davis JC, Van der Heijde DM, Dougados M, et al. Baseline factors that influence ASAS20 response in patients with ankylosing spondylitis treated with a recombinant human tumor necosis factor-Fc fusion protein, J Rheumatol, 2005, 32: 1751-1754.
  • 4Francois RJ, Neore L, Sieper J, et al. Immonohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis, 2006, 65:713-720.
  • 5Crew MD, Effros RB, Walford RL, et al. Transgenic mice expressing a truncated Peromyscus Leucopus TNF-α gene manifest an arthritis resembling ankylosing spondylitis. J Interferon Cytokine Res, 1998, 18: 219-225.
  • 6Cailin Henderson, John C Davisl. Drug insight: anti-tumornecrosis-factor therapy for ankylosing spondylitis. Nat Clin Pract Rheumatol, 2006, 2: 211-218.
  • 7Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spandylitis Disease Activity Index. Arthritis Rheum, 2004, 51: 154-159.
  • 8Anderson JJ, Baron G, van der Heijde D, et al. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum, 2001, 44: 1876-1886.
  • 9Jauregui E, Conner-Spndy B, Russell AS, et al. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy. J Rheumatol, 2004, 31 : 2422-2428.
  • 10Pavy S, Brophy S, Calin A, et al. Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study. J Rheumatol, 2005, 32: 80-85.

共引文献58

同被引文献52

  • 1周巧龙,童荣璋,夏建锋,王亮.CT导引下骶髂关节介入注射治疗强直性脊柱炎的临床应用[J].医学影像学杂志,2004,14(7):595-596. 被引量:3
  • 2李丹,曹野,宋书林,陈华,彭荣,黄新阶,陈立岩.C型臂X线机引导下骶髂关节穿刺治疗强直性脊柱炎[J].实用放射学杂志,2006,22(2):185-185. 被引量:1
  • 3Bolognia JL,Jorizza JL,Rapini RP,et al.皮肤病学[M].朱学骏,王宝玺,孙建方,等,译.2版.北京:北京大学医学出版社,2010:733-737.
  • 4Muller H, Rehberger P, Giinther C, et al. Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma [ J ]. Br J Dermatol, 2012,166 : 343- 353.
  • 5Mouthon L, Mestre-Stanislas C, Berezne A, et al. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis[ J]. Ann Rheum Dis,2010,69 : 214-217.
  • 6Baron M, Sutton E, Hudson M, et al. The relationship of dyspnoea to function and quality of life in systemic sclerosis [ ] ]. Ann Rheum Dis,2008, 67 : 644-650.
  • 7Khanna D, Hays RD, Park GS, et al. Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument [ J]. Arthritis Rheum,2007,57 : 1280-1286.
  • 8Georges C, Chassany O, Mouthon L, et al. Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis [ J]. Rev Med Interne,2004,25 : 16-21.
  • 9Khanna D, Furst DE, Clements PJ, et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial [ J ]. J Rheumatol, 2005, 32 : 832-840.
  • 10Schieir O, Thombs BD, Hudson M, et al. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis [J]. Arthritis Care Res ,2010,62: 409-417.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部